Bleeding and thrombotic events in patients with colorectal cancer treated with bevacizumab and receiving novel oral anticoagulants and antiplatelet medications.

被引：0
|
作者：
Rho, Shinji
Wang, Chris
Dehkordi, Seyed Hamed Hosseini
Sears, Jerod J.
Hu, Zishuo Ian
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
104
引用
收藏
页码：104 / 104
页数：1
相关论文
共 45 条
  • [1] Thrombotic events in patients with metastatic colorectal cancer treated with FOLFIRI plus bevacizumab
    Al-Shamsi, Humaid O.
    Anjum, Mahraz
    Al Farsi, Abdulaziz
    Shen, Hua
    Linkins, Lori-Ann
    Cook, Richard J.
    Major, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [2] Thrombotic events in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab.
    Al-Shamsi, Humaid O.
    Anjum, Mahraz
    Al Farsi, Abdulaziz Mohammed
    Shen, Hua
    Cook, Richard J.
    Linkins, Lori-Ann
    Major, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab
    Al-Shamsi, Humaid O.
    Al Farsi, Abdulaziz
    Anjum, Mahraz
    Shen, Hua
    Zbuk, Kevin
    Cook, Richard J.
    Linkins, Lori-Ann
    Major, Pierre
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 6 (03) : 274 - 279
  • [4] Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
    Wallvik, Niklas
    Renlund, Henrik
    Sjalander, Anders
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (01) : 315 - 323
  • [5] Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
    Niklas Wallvik
    Henrik Renlund
    Anders Själander
    Journal of Thrombosis and Thrombolysis, 2021, 52 : 315 - 323
  • [6] Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants
    Angeli, Francesco
    Bergamaschi, Luca
    Armillotta, Matteo
    Sansonetti, Angelo
    Stefanizzi, Andrea
    Canton, Lisa
    Bodega, Francesca
    Suma, Nicole
    Amicone, Sara
    Fedele, Damiano
    Bertolini, Davide
    Impellizzeri, Andrea
    Tattilo, Francesco Pio
    Cavallo, Daniele
    Bartoli, Lorenzo
    Di Iuorio, Ornella
    Ryabenko, Khrystyna
    Alvarez, Marcello Casuso
    Marinelli, Virginia
    Asta, Claudio
    Ciarlantini, Mariachiara
    Pastore, Giuseppe
    Rinaldi, Andrea
    Pomata, Daniela Paola
    Caldarera, Ilaria
    Pizzi, Carmine
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, 24 (06) : 813 - 821
  • [7] The Risk of Bleeding in Patients Receiving Ibrutinib Combined with Novel Direct Oral Anticoagulants
    Raz, Michal Ariela
    Arnason, Jon E.
    Bairey, Osnat
    Shvidel, Lev
    Aviv, Ariel
    Ben Baruch, Sharon
    Perry, Chava
    Sarid, Nadav
    Varon, David
    Kirgner, Ilya
    Herishanu, Yair
    Avivi, Irit
    BLOOD, 2019, 134
  • [8] The risk of bleeding in patients receiving ibrutinib combined with novel direct oral anticoagulants
    Raz, Michal Ariela
    Arnason, Jon
    Bairey, Osnat
    Shvidel, Lev
    Aviv, Ariel
    Ben Baruch, Sharon
    Perry, Chava
    Sarid, Nadav
    Kirgner, Ilya
    Dvid, Varon
    Herishanu, Yair
    Avivi, Irit
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (02) : E31 - E33
  • [9] Adverse Events in Patients with Cancer Treated with Direct Oral Anticoagulants and Cancer Therapy
    Truong, Huong L.
    Szabatura, Audrea
    Leblebjian, Houry
    Harris, Christy
    Connors, Jean M.
    BLOOD, 2017, 130
  • [10] Prediction of hemorrhagic and thrombotic events in patients with mechanical heart valve prostheses treated with oral anticoagulants
    Van Leeuwen, Y.
    Rosendaal, F. R.
    Cannegieter, S. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (03) : 451 - 456
12345